Search

Board Moves June 15, 2017

Bruce Linton, current non-executive director of Auscann Group Holdings, has appointed David Pryce as his alternate director.  Mr  Pryce is vice president of international market expansion and global government relations at Canopy Growth Corporation, the largest cannabinoid medicine producer in North America. Auscann has also appointed Dr Danial Schecter, chief medical officer at Cannabinoid Medical Clinic in Toronto, as chief medical advisor.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLPC cresa

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Share Transactions

27/01/17
$0 Sold
20/10/14
$2.1m Bought
17/10/14
$2.1m Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

249th↓Aus Asia Minerals$73k
296th↑Haranga Resources$26k
297th-Meteoric Resources$25k
299th↑De Grey Mining$24k
300th↓MacPhersons Resources$23k
507 listed resources companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer